(±)- Trans -2-(3-methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist

Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Constantinos A. Demopoulos, R. Neal Pinckard, D J Hanahan · Journal of Biological Chemistry · 1979 · 1.2K citations · Full text

Proteinlipid Interaction, Platelet-activating Factor, Rabbit Platelets +20

Antihypertensive activity of an alkyl ether analog of phosphatidylcholine

Merle L. Blank, Fred Snyder, Lawrence W. Byers et al. · Biochemical and Biophysical Research Communications · 1979 · 558 citations

Medicine, Physiology, Pharmacological Agent +4

Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives

B. Boris Vargaftig, Jean Lefort, Michel Chignard et al. · European Journal of Pharmacology · 1980 · 415 citations

Inflammation, Asthma, Thrombopoiesis +11

CV-3988 - A specific antagonist of platelet activating factor (PAF)

Zen‐ichi Terashita, Susumu Tsushima, YOSHIO YOSHIOKA et al. · Life Sciences · 1983 · 336 citations

Inflammation, Thrombosis, Thrombopoiesis +12

Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.

J. Casals‐Stenzel, G. Muačević, K. H. Weber · Journal of Pharmacology and Experimental Therapeutics · 1987 · 268 citations